In a big step towards developing a pill that could make you more egalitarian, researchers have found that a drug that prolongs the effects of the brain chemical dopamine boosts compassion.
Dopamine is a brain chemical associated with reward and motivation in the prefrontal cortex of the brain.
In the study, published online in the journal Current Biology, the researchers used the drug tolcapone, which is already approved by the US Food and Drug Administration (FDA) for use in treatment of people with Parkinson's disease.
"We typically think of fair-mindedness as a stable characteristic, part of one's personality," said co-principal investigator Ming Hsu, assistant professor at the University of California - Berkeley.
"Our study does not reject this notion, but it does show how that trait can be systematically affected by targeting specific neurochemical pathways in the human brain," Hsu noted.
The study involved 35 participants, including 18 women. On two separate visits, the study participants received a pill containing either a placebo or tolcapone that prolongs the effects of dopamine.
Participants then played a simple economic game in which they divided money between themselves and an anonymous recipient.
After receiving tolcapone, participants divided the money with the strangers in a fairer, more egalitarian way than after receiving the placebo.
Previous studies had shown that economic inequity is evaluated in the prefrontal cortex, a core area of the brain that dopamine affects,
"We have taken an important step toward learning how our aversion to inequity is influenced by our brain chemistry," first author of the current study Ignacio Saez from the UC Berkeley pointed out.
"Studies in the past decade have shed light on the neural circuits that govern how we behave in social situations. What we show here is one brain 'switch' we can affect," Saez noted.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
